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Graphene-Based Technologies for Tackling COVID-19  
and Future Pandemics
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and Nazmul Karim*
The COVID-19 pandemic highlighted the need for rapid tools and 
technologies to combat highly infectious viruses. The excellent electrical, 
mechanical and other functional properties of graphene and graphene-like 
2D materials (2DM) can be utilized to develop novel and innovative devices 
to tackle COVID-19 and future pandemics. Here, the authors outline how 
graphene and other 2DM-based technologies can be used for the detection, 
protection, and continuous monitoring of infectious diseases including 
COVID-19. The authors highlight the potential of 2DM-based biosensors in 
rapid testing and tracing of viruses to enable isolation of infected patients, 
and stop the spread of viruses. The possibilities of graphene-based wearable 
devices are discussed for continuous monitoring of COVID-19 symptoms. 
The authors also provide an overview of the personal protective equipment, 
and potential filtration mechanisms to separate, destroy or degrade highly 
infectious viruses, and the potential of graphene and other 2DM to increase 
their efficiency, and enhance functional and mechanical properties. Graphene 
and other 2DM could not only play a vital role for tackling the ongoing 
COVID-19 pandemic but also provide technology platforms and tools for the 
protection, detection and monitoring of future viral diseases.
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situation is not only affecting the health of 
the population but also has clear significant 
impact on global economy, political and 
social aspects. Additionally, the dramatic 
impacts on financial markets all over the 
world have caused unemployment, busi-
ness failure, hardship for certain industries 
including tourism and aviation, and created 
an unprecedented level of risk for the inves-
tors. Many scientists have already shifted 
focus of their research into developing 
novel technologies to combat COVID-19, 
and several vaccines have already been 
developed. According to data from Inter-
national clinical Registry Platform, 323 
randomised controlled trials and 134 non-
randomised studies of the COVID-19 vac-
cines are currently ongoing,[2] and a total of 
4.9 billion vaccine doses have been admin-
istered (August 2021).[1] However, time will 
be needed to vaccinate the mass population 
worldwide. Additionally, vaccines may pro-
vide short-term immunity and the introduc-
tion of new COVID-19 variants (e.g., alpha, 
beta, gamma, and delta) has made the situation worse, as they 
spread quicker than previous variants, and are associated with a 
higher risk of death.[3] While scientists turned their attention into 
developing new technologies to combat COVID-19,[4,5] as evident 
from hundreds-of-thousands COVID-19 related research journal 
papers published so far since the outbreak, there remains a lack 
of robust technologies that can facilitate detection, monitoring 
and protection from COVID-19.
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/adfm.202107407.
© 2021 The Authors. Advanced Functional Materials published by Wiley-
VCH GmbH. This is an open access article under the terms of the Crea-
tive Commons Attribution License, which permits use, distribution and 
reproduction in any medium, provided the original work is properly cited.
1. Introduction
The emergence of coronavirus disease 2019 (COVID-19) has been 
the greatest threat of this century to the worldwide community, 
due to the global spread and severity of the disease. As of Aug 
2021, globally there have been ≈214.5 million confirmed cases 
of COVID-19 in 170 countries, and ≈4.5 million deaths reported 
to World Health Organization (WHO).[1] Such an extraordinary 
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Graphene, since its isolation in 2004, has received much 
attention from the researcher community, owing to its incred-
ible mechanical, thermal, electrical and other properties.[7] In 
addition, the isolation of graphene has unveiled a wide range of 
graphene-like 2D materials (2DM) with outstanding properties. 
Such materials could be assembled into one multilayer stack and 
create heterostructure-based multifunctional devices, enabling 
extraordinary control of their properties and functionality. Gra-
phene has already demonstrated potential for biosensing,[8–10] 
wearable electronics,[11–13] and filtration[14,15] which could be used 
for the detection, continuous monitoring and the protection from 
the infectious diseases including COVID-19 (Figure 1a–e).[16–18]  
The incredible properties of graphene could be exploited to man-
ufacture next generation personal protective equipment (PPE) or 
wearable e-textiles for fighting COVID-19. For instance, robust 
nano-scaled multifunctional devices can be designed using a 
combination of electrically and optically active 2D materials 
and stimuli-responsive biomaterials to perform bio-detection, 
sensing, self-cleaning, and self-regeneration functions.
Here, we explore how graphene, other 2DM and composites 
could potentially offer alternative or complementary solutions 
for detecting and monitoring COVID-19. We also discuss their 
role for developing novel biosensors and wearable technologies, 
which can be designed to detect virus antigens or antibodies, as 
well as continuous monitoring of COVID-19 symptoms, thus 
helping to contain the pandemic by controlling the reproduc-
tion rate (R). We also review the current PPE and virus filtra-
tion techniques and discuss the potential of 2D materials 
for manufacturing sustainable and highly effective anti-viral 
PPE and virus flirtation techniques. Finally, we investigate 
future research directions for graphene-based technologies to 
develop novel detection and protection technologies to combat 
COVID-19 outbreaks as well as any future virus outbreaks.
2. The Detection and Continuous Monitoring:  
Test and Trace
The detection of COVID-19 is considered as a critical step for 
the isolation and treatment of COVID-19 infected patients. In 
addition, the rapid and extensive testing helps contact tracing of 
close contacts of anyone who has tested positive for COVID-19, 
and isolate them to stop the spread of the virus. Thus, the test and 
trace service enable control of the reproduction rate (R), and 
Figure 1. COVID-19 and potential graphene-based technologies for tackling COVID-19 virus. a) The structure of a COVID-19 virus and transmission 
(via water, air, food, blood, and touch) to infect lungs of a human body. b) A COVID-19 patient’s infection trajectory (blue lines) in context of two sur-
veillance regimens (circles), where the lateral flow test is more likely to detect infection during the transmission window (shading) than PCR, despite 
its lower analytic sensitivity. Reproduced with permission.[6] Copyright 2020, Massachusetts Medical Society. c) Potential graphene-based PPEs for the 
protection against viruses. d) Prospective graphene-based biosensors to enable rapid detection of COVID-19 and e) Future graphene-based wearable 
technologies for continuous monitoring of physiological conditions.
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helps governments set strategies and take necessary control 
measures including local or national lockdowns to contain 
the pandemic and save lives. Currently, several COVID-19 test 
methods are available on the market,[19] which can broadly be 
categorized into viral tests (to detect the current infection) and 
antibody testing (also known as a serologic test). Two types of 
viral tests can be used: nucleic acid amplification tests (NAATs) 
and antigen tests. The WHO and US Centres for Disease Control 
and Prevention recommend real-time reverse transcription poly-
merase chain reaction (PCR) for diagnosis of COVID-19 infection 
which involves the detection of viral RNA using NAATs.[20]
PCR is the most widely used gold standard for testing 
COVID-19 infections due to its high sensitivity and specificity.[21] 
However, a PCR test is a time-consuming process which requires 
a sophisticated laboratory and machines, trained personnel and 
logistics for transporting samples. In addition, the possibility of 
obtaining false-negative results from PCR tests can be as high 
as ≈29%,[22] which is a growing concern. Furthermore, delays 
in obtaining PCR results leave a window in which the shedding 
of infectious virus occurs and the control of onward transmis-
sion remains a challenge. Alternative antigen lateral flow tests 
provide rapid results but suffer from inferior sensitivity and 
specificity to PCR. Nevertheless, rapid antigen tests can pro-
vide useful information as point-of-care testing, thereby inter-
ests in their performance are growing with a particular focus 
on the sensitivity and overall specificity.[23] The antibody-based 
test methods are promising but it can take weeks or months for 
antibodies to appear after the initial exposure. Therefore, there 
remains an unmet need for a rapid and low-cost testing method 
with excellent sensitivity and specificity that would enable wide-
spread population-level testing at scale, as well as monitoring 
of the COVID-19 infection. Graphene and other 2DM-based 
biosensors and wearable technologies could potentially offer 
alternative or complementary alternative solutions for detecting 
and continuous monitoring of COVID-19 and other viruses.
2.1. Biosensors
Biosensors have seen significant interest in recent years due to 
their ability to provide rapid, sensitive, portable, miniaturized 
and inexpensive alternative platforms to traditional diagnostics 
systems.[24] A typical biosensor consists of three parts: “biorecep-
tors” unit (for example, enzyme, antibody or DNA) in combina-
tion with ion conductive materials that recognize the analyte, a 
physio-chemical signal transducer (for example, electrochemical, 
optical or piezoelectric) that translates this bio-recognition event 
into a useful signal, and a reader device (Figure  1d).[25] Such 
devices could potentially detect viruses including COVID-19 with 
remarkable sensitivity and specificity, which is extremely impor-
tant to determine  the  usefulness and reliability of test results.
Proteins or DNA are usually attached to robust functional 
synthetic materials to form a bio-detection unit. Such composite 
surfaces provide high sensitivity, fast response, and revers-
ibility of bio-recognition events.[26] Bio-recognition as other 
biological processes operates with ionic current.[27] Therefore, 
ion conductive, and ion and electron conductive polymers are 
commonly used for the formation of bio-sensitive surfaces.[28] 
The enhanced sensing functionality of synthetic and natural 
polyelectrolytes comes from the fact that the charge state of 
the polyelectrolyte depends strongly on external conditions. 
Upon changing such conditions, the macromolecules are able 
to change their charged state releasing ions and conformation, 
creating a signal that can be used for transduction.[29] Recent 
advances in transduction systems, nanotechnology and genetic 
engineering have significantly improved the detection per-
formance of biosensors.[30,31] Depending on the transduction 
systems, biosensors can be categorized into three main types: 
electrochemical, optical, and piezoelectric biosensors. Electro-
chemical biosensors convert the chemical signal into an elec-
trical signal and monitor changes in charge distribution over 
the transducer surface based on potentiometric, amperometric, 
or impedimetric transduction principles. An optical signal is 
emitted in optical biosensors, which is directly proportional 
to the concentration of the analyte. Piezoelectric biosensors 
measure the alterations in resonate frequency due to a mass 
bound on the piezoelectric crystal surface.
Biosensors for detecting COVID-19 and other viruses can be 
designed to detect virus antigens, antibodies produced against 
a virus or the viral genome.[33] Indeed, it is easier to detect viral 
antigens as they are displayed on the outer surface of the virus 
and can strongly be attached to receptors or antibodies car-
ried by the biosensor. The majority of biosensors developed 
so far, however, have focused on the detection of the influenza 
viruses.[34–36] This is mainly due to the fact that the influenza 
virus has many harmful subtypes with annual morbidity and 
mortality worldwide. These circumstances have motivated the 
development of technologies for fast diagnosis with the reli-
ability found in biosensors. Nevertheless, biosensors have 
been developed to detect SARS-CoV as a faster and more sensi-
tive alternative to the RT-qPCR and serological tests.[37–39] The 
recent emergence of deadly and highly infectious SARS-CoV-2 
(COVID-19) viruses has forced scientists to develop alternative 
diagnostics for quick and sensitive detection of COVID-19 fol-
lowed by contact tracing and containment strategies. Further-
more, biosensing devices developed for the detection of Influenza 
and SARS-CoV viruses could be used as models for developing 
similar devices detecting COVID-19, as the biological mate-
rials (e.g., antibodies, antigens, DNA, etc.) are essentially the 
same.[40] Recent studies[20,41–46] have reported several prom-
ising nanotechnology-based biosensing devices for diagnosing 
COVID-19 via both nucleic acid- and antigen-based detec-
tion, including platforms based on gold nanoparticles, carbon 
nanotubes and quantum dots. However, the use of such nano-
materials is problematic due to their inconsistent signal ampli-
fication and the presence of metallic impurities.[47]
Graphene and graphene-like 2D materials including transi-
tion metal dichalcogenides, graphitic carbon nitride, MXenes, 
hexagonal boron nitride (h-BN), and transition metal oxides, 
have shown great promise as transduction system and sup-
porting substrates for fabricating next generation biosen-
sors.[48,49] Extremely high surface area, coupled with broad 
range of electronics and optical properties, make graphene 
and graphene-like 2D materials ideal for biosensing applica-
tions. Additionally, 2D materials can be combined easily in 
one multilayer stack to fabricate heterostructure devices with 
tuneable functionalities and properties. Furthermore, graphene 
and graphene-like 2D materials can be tailored to selectively 
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respond to specific analytes with extremely high sensitivity via 
modifying their surface functionalities or defect engineering, 
which is particularly attractive for rapid and easy-to-use virus 
detection. For example, oxygen-containing functional groups 
of graphene oxide (GO) and reduced graphene oxide (rGO) can 
be fine-tuned, which is often crucial for binding interactions 
between graphene derivatives and biomolecules.[50] Indeed, 
graphene-based innovative biosensing devices have already 
been reported and summarised in several studies.[51–55] Cur-
rent 2D materials-based biosensors can be categorized as: elec-
trode-based devices, including electrochemical, and field-effect 
transducers, and optical systems mainly relying on sensing by 
fluorescence, surface plasmon resonance (SPR), and surface-
enhanced Raman scattering.[56] Among them, single to few layers 
graphene-based field-effect transistors (FET) have shown promise 
due to their ultra-sensitivity and low-noise detection, thereby 
providing quick measurements even in the presence of small 
amounts of analyte.[57] Graphene-based electrical sensors provide 
several advantages including small size, large surface area, fast 
electron transfer, fast response time, high sensitivity, and reduced 
surface contamination. However, they are limited to measure 
current changes only, low spatial resolution and potentially dam-
aging samples, which may affect results.[58] Similarly, graphene-
based optical sensors provide high spatial resolution, wide and 
deep detection range, high sensitivity and precision, accurate and 
fast detection. However such sensors can suffer from low light 
absorption rate, aggregation, and precipitation of high concen-
trated sample, which may affect the optical detection.[59]
Since the COVID-19 outbreak, researchers have turned 
their attention into developing graphene-based biosensors 
(Table 1). Recently, a graphene-based FET biosensor was devel-
oped for detecting COVID-19, using spike protein antibodies 
as the detection probe (Figure 2a).[32] In this work, the sensor 
performance was evaluated using an antigen protein, cul-
tured virus, and nasopharyngeal swab specimens from both 
COVID-19 patients and control subjects, which demonstrated 
the detection of SARS-CoV-2 spike protein at concentrations 
of 1 fg mL−1 in phosphate-buffered saline and 100 fg mL−1 
clinical transport medium. Additionally, the graphene-based 
FET sensor clearly discriminated between patient and control 
samples, and responded to patient samples diluted as much 
as 1:1 × 105 (242 copies mL−1; Figure 2b,c). Although the limit 
of detection (LOD) of the developed COVID-19 FET sensor is 
slightly higher than the current molecular diagnostic test of 
COVID-19 (50–100 copies mL−1),[64] the LOD is low enough 
for practical use. The reported system proved to be advanta-
geous for detecting the COVID-19 virus from clinical samples 
without any pre-processing and with a large dynamic range, but 
further development of novel materials for FET sensors would 
be needed for more accurate detection by reducing noise. In 
another study,[61] an MXene–graphene FET sensor was devel-
oped for detecting influenza and SARS-CoV-2 viruses. In this 
work, an ultra-sensitive virus-sensing transduction material 
was developed, which combines the high chemical sensitivity of 
MXene and the continuity of large-area high-quality graphene. 
The developed FET sensors provide low LOD (125 copies mL−1 
for the influenza virus and 1 fg mL−1 for the recombinant 2019-
nCoV spike protein), as well as faster response time (≈50 ms) 
than existing detection techniques. The reported low-cost, ultra-
sensitive, fast-responding, and high specific 2D materials-based 
COVID-19 sensor will further advance the biosensing field by 
innovating novel devices for detecting highly infectious viruses 
including COVID-19.
Thanks to excellent electrical properties and large surface 
area, graphene and other 2DM will be better candidate for fab-
ricating next generation FET-based biosensors to detect infec-
tious viruses including COVID-19. Graphene provides higher 
electron mobility but suffers from current leakage and reduced 
sensitivity due to its zero-band gap. In contrast, a larger band 
gap can be achieved with other 2DM such as MoS2, WSe2, 
and MnO2, which can be switched between semiconducting and 
insulating states. Thus, current leakage can be minimised, and 
higher sensitivity can be achieved. Furthermore, the surface 
modification or functionalisation of 2DM can be carried out 
to tailor the band gap and carrier concentration. Nevertheless, 
the successful commercialisation of such biosensors will also 
depend on the life-time, storage, and operation time, which 
need to be considered at the design stage of a biosensors.[56]
For biosensing, it is important to propose new composite 
materials that can operate with both ionic and electronic cur-
rents. Such a 2D composite can be built using polyelectrolytes, 
GO and electronically conductive 2D materials. GO is a deriva-
tive of graphene that is widely used for the design of biorecog-
nition units of biosensors.[65] GO has an ideal compatibility 
with soft bio-interfaces and demonstrates similar ionic trans-
port properties as polyelectrolytes.[66] So it can be used as an ion 
conductive component in composites and also it can be deco-
rated by polyelectrolytes and biomolecules to achieve additional 
functionality.[67] It was shown that the change of ionic concen-
tration in the interior of the GO-polyelectrolyte composite mate-
rial can be used as gating for the building of transistors oper-
ating with ionic current.[68] This functionality can be used for 
sensing of the presence of the virus.[69] The properties of such 
composite transistors depend on electrochemical environment. 
Table 1. Summary of recently developed graphene-based biosensors for detecting COVID-19.
Detected element Sensing material and sensor type Limit of detection (LOD) Ref.
SARS-CoV-2 spike protein Graphene (FET sensor) Culture medium: 1.6 × 101 pfu mL−1
Clinical samples: 2.42 × 102 copies mL−1
[32]
SARS-CoV-2 spike protein WSe2 (FET sesnor) 25 fg µL−1 in 0.01X phosphate-buffered saline (PBS). [60]
Influenza virus and 2019-nCoV MXene-graphene (FET Sensor) 125 copies mL−1 for the influenza virus
1 fg mL−1 for the recombinant 2019-nCoV spike protein
[61]
SARS-CoV-2 Graphene (nanoresonator sensors) 10 copies per test [62]
SARS-CoV-2 BK7/Au/PtSe2/Graphene (surface plasmon  
resonance (SPR) biosensor)
Sensitivity: 183.33°/refractive index unit (RIU) in  
SPR angle (θSPR)
[63]
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The positively charged surfaces made of cationic polyelectro-
lytes will attract biological objects, including COVID-19. Due 
to electrostatic interactions between viruses and polyelectro-
lytes, we can achieve a switch in ionic current in the transistors 
(detection and signalling function).[69]
2.2. Wearable Devices
According to recent NHS (UK) data (2019), approximately 
307 million patient consultations take place every year at GP 
surgeries. Additionally, outpatient visits at hospitals have approxi-
mately doubled over the past decade (from 54 to 94 million per 
year), adding extra expenditure of ≈£8 billion per year to NHS 
costs.[70] To tackle this ever-increasing pressure on healthcare 
system, and provide quality healthcare services to the mass 
population, the NHS has published a long-term plan with a 
vision to move towards digital health services.[70] Wearable 
technologies such as activity trackers and smartwatches will 
play significant role in implementing such a plan via early pre-
diction, and continuous monitoring and tracking of diseases. 
Such wearable devices can provide greater understanding into 
our health and well-being,[71] by collecting real-time physi-
ological data instead of an occasional snapshot during medical 
appointments. Furthermore, it allows detection of deviations 
in health data from an individual’s “typical” baselines, which is 
fundamentally a different approach from the current practice 
that is based on population statistics.
Now as the current COVID-19 pandemic is ongoing, the 
potential of such wearable devices has become increasingly 
apparent. The main symptoms of coronavirus (COVID-19) 
include a high temperature (98%), a new continuous cough 
(65%) and shortness of breath (55%).[72] Additional symptoms 
include silent hypoxemia (an abnormally low level of oxygen 
Figure 2. Graphene-based biosensors and wearable e-textiles for tackling COVID-19. a) Graphene-based FET sensor for detecting SARS-CoV-2 spike 
protein from COVID-19 patients. b,c) Comparison of response signal between control and patient samples. Reproduced with permission.[32] American 
Chemical Society. d) Fully inkjet-printed graphene-based wearable e-textiles for monitoring heart rate. e) Flexible and wearable graphene-based textiles 
sensors for monitoring human activity. f) Concept future wearable e-textiles garment for remote monitoring of signs for early detection of asymptomatic 
and pre-symptomatic cases of COVID-19 and other viruses.
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in the blood), and a loss or change of sense of smell or taste. 
Therefore, consumer-grade wearable devices which are readily 
available and interoperable with smartphones, could potentially 
be used for continuous monitoring of vital signs, although 
they have limitations in accuracy and measurement modali-
ties.[73] Three most well-known commercial wearable devices 
are: FitBit, Apple Watch, and Oura Ring, which offer heart rate 
and physical activity measurements but not body temperature, 
respiratory rate or oxygen saturation level. Additionally, FitBit and 
Oura Ring have not received U.S. Food and Drug Administration 
approval yet for remote monitoring of patients’ physiological 
conditions.[73] Projects like Snap40 were kicked off well before 
COVID-19 outbreak (in 2017 but report yet to be published) 
involving 250 NHS patients, where a single wearable device was 
attached on the upper arm to continuously monitor skin tem-
perature, respiratory rate, oxygen saturation, relative change in 
systolic blood pressure, heart rate, and body movement.[74]
Since the COVID-19 outbreak, researchers have already 
started investigating the use of wearable technology for early 
detection of asymptomatic and pre-symptomatic cases of 
COVID-19. In a recent study,[75] pre-symptomatic cases of 
COVID-19 were detected from the smartwatch data including 
heart rate, sleep time and number of daily steps via investi-
gating correlations between different metrics, and detecting 
unusual physiology. The health data of 32 COVID-19 infected 
individuals out of 5,300 participants was collected from smart 
devices including Apple Watch and FitBits. The elevated resting 
heart rates (relative to individual’s baseline), and the increased 
heart rate in relation to number of steps were observed. It was 
found that 26 out of 32 (81%) COVID-19 infected participants 
displayed aberrant physiological signals 4–7 days prior to onset 
of symptoms or diagnosis. However, such study fails to differen-
tiate COVID-19 from other viral infections, and also questions 
its diagnostic performance due to a lack of additional physi-
ological information (depends only on heart rate), effects of 
environmental, behavioural and other external factors (such as 
drug, alcohol, travel, stress, diet, and other health conditions).
In another study,[76] it was investigated that how smartwatch 
data and self-reported symptoms can help to detect COVID-19. 
The data collected from a pool of over 30 000 participants shows 
that the resting heart rate data alone is not a major differen-
tiator between COVID-19 positive and negative cases in the 
area under the curve (AUC) of the receiver operator character-
istic (ROC curve was 0.52), whereas accuracy improves as sleep 
data and activity metrics were added to resting heart rate data 
(AUC increased to 0.72), and improves further (AUC increased 
to 0.80) as self-reported symptoms were addressed. However, 
this methodology is also unable to differentiate COVID-19 from 
other viral infections, and does not take other physiological, 
behavioural, environmental and external factors into considera-
tion. Additionally, such devices are bulky and rigid, and most 
importantly not comfortable to wear.
With the aim to achieve wearer’s comfortability, researchers 
have put efforts into developing on-body skin-integrated sen-
sors (soft electronic tags/patch that couple intimately to the 
skin) that can measure respiratory biomarkers (such as cough 
intensity/frequency/sound, respiratory effort and rate).[77] A 
company called VitalConnect (San Jose, CA) has introduced 
a single-use chest patch in nursing homes to track and con-
tinuous monitoring of heart rate and respiratory rate of 
vulnerable elderly patients.[73] In another project by Imperial 
College (London, UK), a temporary NHS facility was setup 
near Heathrow airport to monitor heath data of quarantined 
travellers. Wearable sensors were used for collecting heath 
data such as temperature, heart rate, and respiratory rate of 
individuals in quarantine.[78]
Wearable e-textiles could provide alternative to existing bulky 
and rigid devices, as they are less visible, and offer more flex-
ibility and comfort to the wearer. Currently, most of the wear-
able e-textiles in the market are based on metal inks such as 
Ag, Cu and Au, due to their high electrical conductivity (usu-
ally around 105 S m−1) compared to polymer-based inks such 
as PEDOT, polypyrroles and polyanilines (usually around 
102 S m−1). However, metal-based inks are non-biocompatible, 
expensive, harmful to the environment and often need higher 
sintering temperature, which may damage heat-sensitive tex-
tiles.[79] Therefore, there remains a need for developing comple-
mentary wearable technologies in order to predict, detect and 
monitor COVID-19 infections.
Recently, graphene-based smart wearable e-textiles[80] have 
received great attention from the researcher community due to 
graphene’s exceptional properties such as outstanding electrical 
and thermal properties. Among them, rGO-based wearable 
e-textiles are particularly of interest,[13,79–82] due to their better 
adhesion to textiles via possible covalent and hydrogen bonding 
between functional groups of textiles and residual oxygen-con-
taining functional groups of rGO. Thus, rGO-based textiles show 
better washing stability, which is one of the key requirements for 
wearable e-textiles. However, rGO suffers from poor electrical 
conductivity due to the defects in the crystal structure and partial 
restoration of the sp2 structure of graphene during the reduction 
process, and may not be suitable for some applications where 
very high electrical conductivity is required. Highly conductive 
and machine-washable graphene-based e-textiles can be pro-
duced via scalable pad−dry−cure method with subsequent roller 
compression and a fine encapsulation of graphene flakes.[83]
In our previous works,[13,81,83,84] it was demonstrated that 
how various sensors (temperature, activity monitoring and 
heart rate) based on graphene textiles can contribute to indi-
vidual’s health and well-being. In the reported works, we par-
ticularly focused and put our efforts on developing highly scal-
able, washable and flexible wearable e-textiles platforms with 
improved electrical conductivity and strength, better sensitivity, 
breathable and comfortable to wear, as well as environmentally 
friendly. Such platform technologies can be used for devel-
oping wearable garments with multimodal and/or multiplexed 
measurements capability, which may ultimately improve the 
performance and reliability of individual sensors by accommo-
dating additional information.[85] Thus graphene-based wear-
able e-textiles could potentially be used for continuous on body 
monitoring of COVID-19 symptoms.
In our other work[86,87] all-inkjet-printed graphene-based 
wearable e-textiles was reported that can be used as a non-
invasive heart monitoring device. The methodology includes 
inkjet printing of graphene-based conductive inks on a rough 
and porous textiles surface for the first time. Inkjet printing 
enables localised deposition of an exact amount of graphene-
based conductive materials at a predefined location. The use 
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of water-based, non-toxic and bio-compatible graphene inks 
could potentially open up the prospect of manufacturing next 
generation smart e-textiles for personalised healthcare applica-
tions including continuous monitoring of COVID-19 infection. 
In our other works,[13,81,83,84] it was demonstrated that how var-
ious sensors (temperature, activity monitoring and heart rate) 
based on graphene textiles can contribute to individual’s health 
and well-being. In the reported works, we particularly focused 
and put our efforts on developing highly scalable, washable and 
flexible wearable e-textiles platforms with improved electrical 
conductivity and strength, better sensitivity, breathable, and 
comfortable to wear, as well as environmentally friendly. Such 
platform technologies can be used for developing wearable 
garments with multimodal and/or multiplexed measurements 
capability, which may ultimately improve the performance 
and reliability of individual sensors by accommodating addi-
tional information.[85] Thus graphene-based wearable e-textiles 
could potentially be used for continuous on body monitoring of 
COVID-19 symptoms.
3. Protection from Viruses
3.1. Personal Protective Equipment (PPE)
Before the COVID-19 pandemic, the world has seen four more 
pandemics since 1900: the “Spanish Flu” in 1918 (caused by 
A(H1N1) virus), the “Asian Flu” in 1957 (caused by A(H2N2) 
virus), the “Hong Kong Flu” in 1968 (caused by A(H3N2) virus) 
and “Swine Flu” in 2009. Such highly infectious viruses have 
taken millions of lives, as they are highly transmittable while 
the infected person may not show any symptoms at all. The 
lungs cells are affected first, once infected with COVID-19 
viruses, which could kill lung cells as well as cause malfunc-
tioning of these cells (known as “syncytia”). Recent data from 
COVID-19 patients shows that clotting chemicals in the blood 
can increase up to 400% higher than normal levels. Addition-
ally, the inflammation in some patients may eventually weaken 
the immune system, causing damage to the rest of the body, 
especially in blood vessels, liver, kidneys, and lungs.[91] Such 
pathogens mainly transmit between humans by three primary 
routes: direct contact, airborne transmission and respiratory 
droplet transmission. PPE can prevent or reduce such contacts 
and droplet exposures by creating a barrier between human 
body and the pathogens.[92]
PPE is considered to be a critical component due to its ability 
to protect users from droplets from coughs, sneezes, and aer-
osol-generating procedures, in addition to other contaminated 
body fluids and surfaces from infected patients.[88] In general, 
protective aprons, gowns or coveralls, masks or respirators, 
gloves, goggles or face shields are used as PPE for healthcare 
workers. There are three basic factors that need to be addressed 
to select effective PPE. First, the type and amount of bodily fluid 
the wearer might be exposed to, and how these fluids might 
transmit to the body. Second, durability and appropriateness of 
the PPE for the particular task. And third, the fit of the PPE to 
the wearer. Gloves are the widely used PPE to protect hands, 
which are usually made of natural or synthetic rubber of sterile 
and nonsterile types. It is important that the gloves used for 
protective purposes are tear/damage-free, fit well and comfort-
ably. Protective aprons, gowns or coveralls are commonly used 
to protect skin and other clothing. They should fully cover the 
torso and sleeve up to the wrist comfortably and properly. To 
protect all or parts of the face (nose, mouth, and eyes) a combi-
nation of PPE types such as masks or respirators, goggles, and 
face shields are used. Protective goggles should fit softly over 
and around the eyes to protect eyes. Masks should fully cover 
the nose and mouth to prevent airborne transmission and res-
piratory droplet transmission. Respirators such as N95, N99, 
or N100 which are capable of excluding particles that are less 
than 5 µm in diameter are widely used as PPE by the healthcare 
workers. When high-risk aerosol-generating procedures (such 
as bronchoscopies) are being performed, a higher level of res-
piratory protection is used where powered air-purifying respi-
rator (PAPR) purifies the air. In some cases, face shields are 
used instead of googles and mask to cover the full face (from 
forehead to the chin and wrap around the sides of the face).
Typically, protective medical wear is made of synthetic fibers 
because of their better liquid barrier properties. In addition, 
they are fabricated as woven, knitted or of non-woven struc-
ture. Disposable medical textiles such as surgical caps, sur-
gical gowns and surgical masks are mainly made of nonwoven 
fabrics, as such fabrication technique offers scalable and eco-
nomical production with superior sterility and infection control 
than other processes. Such disposable medical textiles generally 
composed of polypropylene fibers, and constructed as spun-
bond–meltblown–spunbond. On the other hand, medical pro-
tective clothing like scrubs is fabricated by weaving cotton or 
polyester/cotton.
Specialist finishes (such as a fluid repellent finish) can be 
applied to all these mentioned disposable or reusable medical 
textiles, to further improve their protection capacity from body 
fluid or hazardous substance contamination. Additionally, anti-
microbial finishes can be highly effective against highly trans-
mittable deadly pathogens (such as coronavirus, hepatitis B 
virus, hepatitis C virus, ebola virus, and human immunodefi-
ciency virus) by preventing infections either by killing or by 
inhibiting viruses and bacteria.[88] Graphene materials (GMs) 
such as graphene, GO, rGO, and graphene quantum dots have 
been investigated as a new type of broad spectrum antimicrobial 
agents.[93] Previous studies have reported anti-bacterial proper-
ties of graphene-based materials via the combined mechanisms 
of bacterial membrane perturbation caused by sharp edges 
and oxidative stress induction.[94] Additionally, the efficacy of 
graphene-based nanocomposites has been investigated with 
other anti-microbial agents including metals (mainly silver), 
metal oxides (e.g., Cu2O), photocatalysts (e.g., TiO2), quaternary 
ammonium salts, and polymers (e.g., polypyrrole).[95] Since the 
outbreak of COVID-19, many companies have rapidly launched 
graphene-enhanced PPE by taking the advantage of graphene’s 
antimicrobial, antistatic, and electrically conductive properties 
to develop face masks with anti-viral properties which can be 
re-sterilised and reused.[96] However, there remains lack of evi-
dence behind such claims. Additionally, graphene face covers 
were removed from Québec’s (Canada) schools and day-care 
centres after a warning from Canada’s national public health 
agency that inhaling the graphene could lead to asbestos-like 
lung damage.[97] Nevertheless, a small quantity of graphene and 
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other 2D materials could be compounded with polymers (e.g, 
PET or PP) (Figure 3a), and then melt-spun into a polyester yarn 
or a polypropylene nonwoven matt (Figure  3b) with enhanced 
mechanical (strength), and improved functional (anti-viral, fluid 
repellent, and moisture management) properties. Such fabrics 
will be used for personal protective clothing to protect health-
care workers and general population from highly infectious 
diseases including COVID-19. Furthermore, graphene-based 
materials can be functionalised or blended with other functional 
polymers, and then coated on (Figure 3b), and cross-linked with 
textiles to produce durable and washable protective clothing that 
could potentially mitigate the risk of inhaling graphene.
3.2. Filtration
Viruses may be transmitted among human populations via various 
pathways.[98] In the following section, we will discuss the impor-
tance of filters in reducing transmission in both air and water 
systems. In many studies, bacteriophages are used as proxies for 
viruses under study because they are harmless to humans and a 
range of them exist with different sizes and surface potentials.
With the exception of hydrogen, the basal plane of graphene 
has shown to be an impermeable species as small as helium,[99] 
due to the π-orbitals forming a dense cloud, blocking transport 
through the aromatic rings. Selective graphene membranes 
can, however, be formed by forming multi-layered structures 
where channels are formed by the interlayer distance between 
adjacent monolayers. GO has extensively been studied for filtra-
tion in both with water[100] and gas filtration[101] due to its ease 
of processability and modification of functional groups allowing 
selectivity to be enhanced. Additionally, the chemical functional 
groups present in GO change the surface energy and give it a 
greater stability in water-based systems than pristine graphene. 
GO is typically produced by the Hummer’s method[102] or 
modified Hummer’s method, and production has progressed 
in recent years towards kiloton scale. GO membranes are pro-
duced from an aqueous solution by vacuum filtration, spray 
coating or bar coating. The resulting lamellar film is composed 
of GO platelets with a high level of orientation to the plane of 
the membrane. The effect of orientation on the anti-bacterial 
activity has shown that exposing bacteria to edges by vertical 
orientation increases bacterial decay.[103] The lamellar structure 
defines pathways for water (or other liquids), and gases to pass 
Figure 3. Graphene-based technologies for sustainable PPE and water purification. a) Hot-melt extrusion process for melt-mixing of graphene and 
other 2DM to fiber polymers. b) Melt-blown nonwoven fabric manufacturing technique for personal protective clothing. c) The application of antimi-
crobial finish on textiles via pad–dry–cure technique. Reproduced with permission.[88] Copyright 2020, American Chemical Society. d) The potential 
sources and pathways of COVID-19 in water systems. Reproduced with permission.[89] Copyright 2020, Elsevier B.V. All rights reserved. e) Nano-porous 
graphene and GO membrane for water purification. Reproduced with permission.[90] Copyright 2015, Royal Society of Chemistry.
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through the membrane by following a tortuous path around 
each principal particle. The nature of the chemical function-
alisation defines the size and surface charge of the channels 
which the permeate must pass. The flux and selectivity of the 
membranes can be modified by chemical treatment of the 
membranes through chemical or thermal reduction,[104] and 
further functionalisation.[101]
Coronaviruses can be found in wastewater streams and 
introduced from hand washing and viral shedding in faces 
from infected individuals.[105] With wastewater streams being 
a potential transmission pathway, it is necessary to understand 
the mechanisms for deactivation or removal. Viruses are pre-
dominantly removed by size exclusion and modified by the 
physiochemical properties of the membrane surface. Mem-
branes have been studied for removal of viruses from water 
streams using conventional membrane materials ultrafiltration 
membranes[106] but are limited by large pore size and limited 
biofouling resistance. Reverse osmosis membranes are less 
well studied[107] but have lower flux and greater energy require-
ments. Membrane properties can be modified by embedding 
of nanoparticles of silver,[108] copper and selenium,[109] and 
zinc oxide,[110] and these can lead to increases in antiviral effi-
cacy. GO membranes have been suggested for inactivation and 
removal of bacteria[111] from water supplies due to their high 
water flux and small, defined pore size. While much has been 
studied about the aerosol transmission of the COVID-19 virus 
through respiration, much less is known about its transmission 
pathway through wastewater streams. Inactivation of viruses 
in water using GO-based materials has been studied by several 
groups[112,113] but not in membrane specific use cases.
Inactivation by photocatalysis has been proposed because it 
is versatile and does not result in addition of further harmful 
substances to the stream[114,115] with TiO2 being the most 
studied material. Other 2D materials with photoactivated 
processes have been studied for their inactivation efficacy of 
viruses[116] including molybdenum disulphide (MoS2) where 
Mo-rich edges are responsible for a 105 increase in efficiency 
over standard MoS2 nanosheets under visible light[117] and chi-
tosan-functionalised MoS2[118] under NIR radiation. These open 
up the possibility of highly efficient inactivation in wastewater 
streams using photocatalytic processes.
Monitoring of COVID-19 in wastewater has been found to 
correlate with virus circulation in the population[119] suggesting 
that systematic quantification can be used to guide govern-
mental control measures. Various graphene-based sensing 
platforms have been studied which could be integrated with 
wastewater treatment plants for real-time quantification and 
planning purposes.[120] The potential of graphene to form a 
simultaneous filtration, inactivation and monitoring membrane 
may be a direction of future progress worthy of study.
Graphene and GO membranes have also been studied for 
inactivation of the COVID-19 virus in aerosols and droplets 
in air. Masks and face coverings have proven an effective con-
trol measure[121] in reducing person to person transmission 
of COVID-19. Up to 50 particles per second can be produced 
when a person is talking,[122] and these particles include drop-
lets (>5  µm diameter) and aerosols (<5  µm diameter). Drop-
lets, being larger mass carry a higher virus load and present 
higher rate of transmission but tend to sediment faster than 
aerosols. Due to their smaller size, aerosols may stay airborne 
for much longer and build up in poorly ventilated rooms over 
time, increasing rate of transmission.[123] Improving air circula-
tion using air conditioning units has been proposed to reduce 
airborne viral load and the use of HEPA[124] filters[125] have been 
studied as to their effectiveness. Air purification systems which 
include filters and active measures such as plasma treatment 
can be an effective method to reduce transmission rate.[125]
Absorption filters can be used to remove viruses from air 
circulation systems and include carbon-based, oxide-based and 
ceramic-based systems. In each of these systems, the electro-
static interactions play roles in the efficacy of the filtration. Acti-
vated carbon is a common filtration media and has been shown 
to be effective at removing a range of contaminants from both 
air and water systems. Activated carbon is a mesoporous mate-
rial with a fractal structure of pores which allows high flux 
and high surface area—both critical factors in determining the 
suitability of the filter for use. Matsushita et al.[126] studied the 
efficacy of 11 different commercially available activated carbon 
materials from a variety of feedstocks to study the effect of 
surface area, elemental contents and functional groups on the 
efficacy of virus removal. The study found that electrophoretic 
repulsive forces, pore size distribution, hydrophobicity all con-
tributed to the level of virus removal. With more hydrophobic, 
lower negative surface charge, high pore volume (20–50  nm) 
activated carbons being more effective in virus removal.
GO is the most studied 2D material for inactivation of 
bacteria and viruses. GO interacts with viruses by hydrogen 
bonding, electrostatic interaction and redox reaction.[127] Effi-
ciency can be enhanced by creating hybrid structures such as 
GO-silver composites enhance natural antiviral defences. Palm-
ieri and Papi[128] provided a review in the early phase of the 
COVID-19 pandemic and discuss various inactivation mecha-
nisms of GMs with viruses. High surface area carbon materials 
like graphene provide a good scaffold for novel virus inhibitors, 
creating a versatile platform filter.
4. Outlook
The COVID-19 pandemic highlights the need for rapidly 
available tools and technologies for detection, protection, and 
continuous monitoring of viruses. Owing to their unique 
physicochemical properties, graphene and graphene-like other 
2DM could play a vital role in combating COVID-19 and other 
future viruses. The excellent electrical, mechanical, thermal, 
and optical properties make them ideal candidate for manu-
facturing biosensors, PPE, wearable electronics, and filtration 
techniques to detect and protect from viruses. Biosensors could 
potentially be used for rapid, low-cost, and mass level testing, 
enabling self-isolation for infectious people. 2DM could be 
used for the development of such biosensors for virus detec-
tion with extremely small dimensions, due to their smaller size 
and excellent physiochemical properties of 2DM. Additionally, 
2DM-based biosensors offer great performance in terms of 
selectivity and sensitivity. The layered 2D structures combined 
with ion-conductive polymers, polyelectrolytes, can convert the 
chemical energy into electrical energy and electrical energy 
into chemical energy. The change of ionic concentration in 
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the interior of the layered composite material can enhance the 
efficiency of bio-detection. A more complex structure with sev-
eral different layers which are differently charged can be self-
assembled into bipolar ionic transistors. Such structures can 
show intrinsic amplification of the signal, increasing sensitivity 
of biosensor.[69] Furthermore, recent progress in 2DM-based 
printed electronics will offer low-cost and large-scale fabrication 
of printed biosensors.[129]
Wearable electronics has demonstrated great potential for 
personalised healthcare applications by monitoring physi-
ological conditions. Graphene and other 2DM offer truly multi-
functional wearable electronics platforms that could potentially 
monitor patients’ vital signs continuously in a non-invasive 
way. Graphene-based wearable electronic devices can be used in 
the early detection of asymptomatic and pre-symptomatic cases 
of COVID-19 and play a vital role in combating the next pan-
demic. However, successful realisation of robust and reliable 
medical-grade wearables will require collaborative joint-efforts 
from materials scientists, electrical engineers, data scientists, 
commercial partners, and healthcare providers.
There has been unprecedented demand and huge shortage 
of PPE to protect the health of HCWs and prevent the spread 
of COVID-19 viruses. The critical shortage of PPE supply has 
been one of major causes for healthcare workers death during 
COVID-19 pandemic. There must be efforts from researchers 
and manufacturers of PPE to improve the performance and 
safety with existing PPE. Graphene, its derivatives and other 
2DM could potentially improve the anti-viral performance of 
PPE, and make them stronger, lighter, and more comfortable to 
wear for HCWs. Additionally, the huge surge in the use of envi-
ronmentally unfriendly plastic-based protective clothing during 
COVID-19 pandemic has been a great concern to the environ-
mentalists. Therefore, many efforts are needed to develop either 
biodegradable or recycled materials-based PPE. The coating or 
compounding of graphene and other 2DMs with such natural 
or recycled materials can improve mechanical and functional 
properties.[13,130]
Graphene and 2DMs have shown promise in filtration and 
inactivation of viruses through forming nanocomposite filters 
and coatings with conventional materials, where their physi-
ochemical and photocatalytic behaviour allows viruses to be 
inactivated. Such filtration devices could be used in air-purification 
and air-conditioning machines to efficiently filter clean the 
COVID-19 and other respire germs present in air. Additionally, 
2DM-based membranes could be used to separate COVID-19 
viruses from water by tuning their microstructural properties 
and interlayer spacing. Furthermore, 2DMs-based photocata-
lyst can be used for inactivation and degradation of COVID-19 
in water directly. Therefore, further work is needed to develop 
next generation smart and sustainable graphene-based mem-
brane that could not only filter the viruses but also destroy and 
sterilise the water.
Graphene-based composite materials have shown promise 
for antiviral treatment by inhibiting viruses from entering the 
host cells. In a previous study silver nanoparticle-modified GO 
(GO-AgNPs) nanocomposites was used as an antiviral agent to 
treat highly infectious porcine reproductive and respiratory syn-
drome virus (PRRSV). Such antimicrobial composites provide 
a broad antiviral activity including 59.2% inhibition efficiency 
against PRRSV.[131] In another study, sulfonated magnetic nano-
particles functionalized with reduced GO was used to capture 
and photothermally destroy herpes simplex virus type 1 (HSV-1) 
using near-infrared (NIR) light with ≈99.99% photothermal 
antiviral activity,[132] which could be used for NIR treatment of 
lungs. However, based on these initial findings, future work 
will be needed to develop graphene-based antiviral treatments 
for COVID-19. Like any other new materials, indeed there has 
been safety and toxicity concerns with graphene and other 
2D materials-based technologies and products, which need to 
be carefully addressed and mitigated for specific commercial 
applications.[133,134]
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